Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects (2016)
- Authors:
- Autor USP: RONSEIN, GRAZIELLA ELIZA - IQ
- Unidade: IQ
- DOI: 10.1161/ATVBAHA.115.306268
- Subjects: ARTERIOSCLEROSE; DOENÇAS CARDIOVASCULARES; MACRÓFAGOS
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2016
- Source:
- Título do periódico: Arteriosclerosis Thrombosis and Vascular Biolology
- ISSN: 1079-5642
- Volume/Número/Paginação/Ano: v. 36, n. 2, p. 404-411, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
RONSEIN, Graziella Eliza et al. Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects. Arteriosclerosis Thrombosis and Vascular Biolology, v. 36, n. 2, p. 404-411, 2016Tradução . . Disponível em: https://doi.org/10.1161/ATVBAHA.115.306268. Acesso em: 15 maio 2024. -
APA
Ronsein, G. E., Hutchins, P. M., Isquith, D., Vaisar, T., Zhao, X. -Q., & Heinecke, J. W. (2016). Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects. Arteriosclerosis Thrombosis and Vascular Biolology, 36( 2), 404-411. doi:10.1161/ATVBAHA.115.306268 -
NLM
Ronsein GE, Hutchins PM, Isquith D, Vaisar T, Zhao X-Q, Heinecke JW. Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects [Internet]. Arteriosclerosis Thrombosis and Vascular Biolology. 2016 ; 36( 2): 404-411.[citado 2024 maio 15 ] Available from: https://doi.org/10.1161/ATVBAHA.115.306268 -
Vancouver
Ronsein GE, Hutchins PM, Isquith D, Vaisar T, Zhao X-Q, Heinecke JW. Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects [Internet]. Arteriosclerosis Thrombosis and Vascular Biolology. 2016 ; 36( 2): 404-411.[citado 2024 maio 15 ] Available from: https://doi.org/10.1161/ATVBAHA.115.306268 - Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
- Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles
- Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
- Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration
- Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone
- Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects
- Time to ditch HOL-C as a measure of PINION HOL function?
- Inflammation, remodeling, and other factors affecting HDL cholesterol efflux
- Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients
- Oxidação do triptofano pelo oxigenio molecular no estado singlete [´OIND.2´(´ANTPOT.1´DELTA IND.g´)]: estudos mecanisticos envolvendo marcação isotopica, espectrometria de massa e quimiluminescencia
Informações sobre o DOI: 10.1161/ATVBAHA.115.306268 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
